January 6, 2025 - 16:35

Blood is a complex and fragile substance that serves as a vital resource for researchers and clinicians aiming to understand various health conditions. Traditionally, blood samples have been utilized for diagnostic purposes due to the relative ease and reduced discomfort associated with drawing blood compared to more invasive procedures like biopsies. However, the stability of these samples during storage and transport has always been a concern.
Recent advancements in technology have led to the development of CryoSCAPE, a groundbreaking method designed to significantly improve the stability of blood samples. This innovative approach addresses the challenges of sample degradation, ensuring that critical biomarkers remain intact for accurate analysis. By preserving the integrity of the samples, CryoSCAPE enhances the reliability of research findings and diagnostic results.
The implications of this technology are profound, potentially leading to improved patient outcomes and more effective treatments. As researchers continue to explore the intricacies of human health, the ability to maintain blood sample quality is an essential step forward in medical science.
June 28, 2026 - 08:54
Innovation Lab Roadshow Brings Adaptive Activities and Assistive Technology to Snohomish County I/DD CommunityA traveling showcase of adaptive tools and hands-on activities is making its way through Snohomish County, bringing new opportunities for people with intellectual and developmental disabilities....
June 27, 2026 - 21:55
World's first 100% electric hydrofoil pilot boat hits the waterArtemis Technologies has unveiled its newest electric hydrofoil vessel, the EF-12, calling it the world`s first completely electric and zero-emissions pilot boat. Designed specifically for...
June 27, 2026 - 00:43
UCF abruptly shuts down some campus libraries and technology resourcesThe University of Central Florida has suddenly shut down several campus libraries and technology resource centers, leaving students and staff scrambling for alternatives. The closures took effect...
June 26, 2026 - 00:10
Partnership with Oxford Nanopore Technologies will support development of RNA liquid biopsy for cancer early detectionA new partnership between a diagnostics company and Oxford Nanopore Technologies is set to push forward the development of a blood test that can spot cancer at its earliest stages. The...